BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2874190)

  • 1. Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus.
    Butterworth J
    J Neurochem; 1986 Aug; 47(2):583-7. PubMed ID: 2874190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases.
    Butterworth J; Yates CM; Reynolds GP
    J Neurol Sci; 1985 Feb; 67(2):161-71. PubMed ID: 2858515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate-activated glutaminase in relation to Huntington's disease and agonal state.
    Butterworth J; Yates CM; Simpson J
    J Neurochem; 1983 Aug; 41(2):440-7. PubMed ID: 6223989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine synthetase activity in Huntington's disease.
    Carter CJ
    Life Sci; 1982 Sep; 31(11):1151-9. PubMed ID: 6128649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
    Arregui A; Emson PC; Spokes EG
    Eur J Pharmacol; 1978 Nov; 52(1):121-4. PubMed ID: 214307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias.
    Yates CM; Butterworth J; Tennant MC; Gordon A
    J Neurochem; 1990 Nov; 55(5):1624-30. PubMed ID: 2213015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective sparing of a class of striatal neurons in Huntington's disease.
    Ferrante RJ; Kowall NW; Beal MF; Richardson EP; Bird ED; Martin JB
    Science; 1985 Nov; 230(4725):561-3. PubMed ID: 2931802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain.
    Curtis MA; Waldvogel HJ; Synek B; Faull RL
    J Chem Neuroanat; 2005 Jul; 30(1):55-66. PubMed ID: 16108100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased proline endopeptidase activity in the basal ganglia in Huntington's disease.
    Pittaway KM; Reynolds GP; Emson PC
    J Neurochem; 1984 Sep; 43(3):878-80. PubMed ID: 6235325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.
    Mann JJ; Kaplan RD; Bird ED
    J Neural Transm; 1986; 65(3-4):277-83. PubMed ID: 2940336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local synchronicity in dopamine-rich caudate nucleus influences Huntington's disease motor phenotype.
    Kasper J; Eickhoff SB; Caspers S; Peter J; Dogan I; Wolf RC; Reetz K; Dukart J; Orth M
    Brain; 2023 Aug; 146(8):3319-3330. PubMed ID: 36795496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine synthetase and fructose-1, 6-diphosphatase activity in the putamen of control and Huntington's disease brain post mortem.
    Carter CJ
    Life Sci; 1983 Apr; 32(17):1949-55. PubMed ID: 6132318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
    Wardlaw JM; Sellar RJ; Abernethy LJ
    Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's chorea: selective depletion of activity of angiotensin coverting enzyme in the corpus striatum.
    Arregui A; Bennett JP; Bird ED; Yamamura HI; Iversen LL; Snyder SH
    Ann Neurol; 1977 Oct; 2(4):294-8. PubMed ID: 214022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease.
    Ferrante RJ; Beal MF; Kowall NW; Richardson EP; Martin JB
    Brain Res; 1987 May; 411(1):162-6. PubMed ID: 2955849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.
    Myers RH; Vonsattel JP; Paskevich PA; Kiely DK; Stevens TJ; Cupples LA; Richardson EP; Bird ED
    J Neuropathol Exp Neurol; 1991 Nov; 50(6):729-42. PubMed ID: 1836225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine aminotransferase in Huntington's disease.
    Wong PT; McGeer PL; Rossor M; McGeer EG
    Brain Res; 1982 Jan; 231(2):466-71. PubMed ID: 6459816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased alanine aminotransferase activity in the Huntington's disease putamen.
    Carter CJ
    J Neurol Sci; 1984 Oct; 66(1):27-32. PubMed ID: 6151588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain peptidases: their possible neuronal and glial localization.
    Koshiya K; Kato T; Tanaka R; Kato T
    Brain Res; 1984 Dec; 324(2):261-70. PubMed ID: 6085024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.